petermd tirzepatide cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says Tirzepatide | DirectMeds

Aleksandr Shapsis, MD

Prescription rates of SGLT2 inhibitors and GLP-1 receptor agonists among adults with type 2 diabetes in the Veterans Health Administration varied by race, with white patients most likely to receive these medications

GLP-1 RA use was consistently associated with improvements in headache frequency, weight reduction, and reduced need for acetazolamide or surgical interventions

A small study offered new data that supports an emerging push to use GLP-1 drugs to manage type 1 diabetes.

Novo Nordisk is set to introduce a lower-cost authorized copy of Ozempic, named Extensior, in South Africa on July 27, in partnership with Acino, enhancing patient access to diabetes treatment.